US Stock MarketDetailed Quotes

VMD Viemed Healthcare

Watchlist
  • 7.830
  • -0.150-1.88%
Close Dec 23 16:00 ET
  • 7.920
  • +0.090+1.15%
Post 16:32 ET
304.87MMarket Cap31.32P/E (TTM)

Viemed Healthcare Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-7.71%12.75M
33.57%10.18M
-88.81%1.18M
62.94%45.21M
72.88%13.28M
73.22%13.81M
54.12%7.62M
46.88%10.5M
23.36%27.75M
-11.22%7.68M
Net income from continuing operations
33.78%3.91M
-36.61%1.48M
5.67%1.6M
64.63%10.24M
42.62%3.48M
176.68%2.92M
140.95%2.33M
-13.90%1.52M
-31.82%6.22M
-40.35%2.44M
Operating gains losses
-60.42%-616K
-259.14%-592K
356.14%146K
127.16%160K
138.54%229K
-284.62%-384K
166.91%372K
83.09%-57K
25.73%-589K
130.48%96K
Depreciation and amortization
7.25%6.41M
21.19%6.31M
31.98%6.29M
39.87%21.86M
35.35%5.92M
44.99%5.98M
39.24%5.21M
40.18%4.76M
38.17%15.63M
40.16%4.37M
Deferred tax
-5,213.64%-3.51M
--0
--0
-182.42%-1.44M
-164.74%-648K
---66K
--0
-197.32%-725K
-55.05%1.75M
-32.09%1M
Other non cash items
424.07%175K
2,664.15%1.36M
3.51%-55K
---219K
---55K
---54K
---53K
---57K
----
----
Change In working capital
44.30%4.52M
103.85%58K
-338.83%-8.29M
6,370.97%7.78M
258.73%2.68M
226.35%3.13M
-158.43%-1.51M
275.73%3.47M
99.09%-124K
45.27%-1.69M
-Change in receivables
136.36%12K
-598.64%-2.2M
-540.38%-6.03M
58.61%-1.06M
-32.24%-525K
95.25%-33K
-84.00%441K
77.71%-941K
65.20%-2.56M
77.60%-397K
-Change in inventory
158.25%113K
142.73%191K
119.69%279K
-256.81%-472K
110.61%42K
40.31%-194K
-27.71%-447K
-90.74%127K
241.98%301K
-2,375.00%-396K
-Change in prepaid assets
-33.98%-1.18M
-12.48%1.42M
-77.95%99K
176.67%2.18M
2,971.88%983K
60.51%-883K
387.46%1.63M
760.29%449K
-1,155.75%-2.84M
-98.43%32K
-Change in payables and accrued expense
8.62%2.96M
335.46%3.25M
-222.40%-3.04M
83.77%4.1M
127.67%269K
-22.84%2.73M
-1,849.37%-1.38M
708.07%2.49M
157.37%2.23M
65.48%-972K
-Change in other working capital
72.58%2.62M
-49.60%-2.61M
-69.78%407K
10.66%3.03M
4,245.45%1.91M
122.11%1.52M
-364.95%-1.75M
-0.37%1.35M
244.94%2.74M
108.54%44K
Cash from discontinued investing activities
Operating cash flow
-7.71%12.75M
33.57%10.18M
-88.81%1.18M
62.94%45.21M
72.88%13.28M
73.22%13.81M
54.12%7.62M
46.88%10.5M
23.36%27.75M
-11.22%7.68M
Investing cash flow
Cash flow from continuing investing activities
41.60%-4.97M
65.33%-11.17M
-37.39%-5.37M
-117.35%-52.11M
-1.56%-7.49M
-39.41%-8.51M
-381.56%-32.21M
-2.57%-3.91M
-21.42%-23.98M
-12.42%-7.38M
Net PPE purchase and sale
29.51%-4.97M
-60.82%-8.17M
-37.39%-5.37M
-7.65%-23.51M
-38.94%-7.47M
-15.88%-7.05M
23.82%-5.08M
-5.34%-3.91M
-14.04%-21.84M
18.06%-5.38M
Net business purchase and sale
--0
----
----
---28.59M
-100.71%-1K
-7,195.00%-1.46M
----
----
--0
--141K
Net investment purchase and sale
----
----
----
99.07%-20K
----
----
----
----
---2.14M
----
Cash from discontinued investing activities
Investing cash flow
41.60%-4.97M
65.33%-11.17M
-37.39%-5.37M
-117.35%-52.11M
-1.56%-7.49M
-39.41%-8.51M
-381.56%-32.21M
-2.57%-3.91M
-21.42%-23.98M
-12.42%-7.38M
Financing cash flow
Cash flow from continuing financing activities
3.87%-5.24M
-77.96%2.48M
-3,535.90%-1.34M
118.51%2.83M
37.78%-3.03M
-135.50%-5.45M
301.72%11.26M
101.56%39K
-186.90%-15.27M
-783.85%-4.87M
Net issuance payments of debt
3.16%-5.21M
-75.25%2.62M
---683K
136.26%2.12M
28.83%-3.1M
-937.38%-5.38M
2,355.53%10.6M
--0
-45.99%-5.84M
-690.56%-4.36M
Net common stock issuance
-34.78%-93K
47.62%-11K
-90.30%-961K
93.88%-594K
100.14%1K
96.33%-69K
99.59%-21K
74.83%-505K
-577.20%-9.71M
---710K
Proceeds from stock option exercised by employees
1,416.67%91K
-96.93%21K
-44.12%304K
360.42%1.3M
-64.80%69K
-93.10%6K
--684K
--544K
152.68%283K
--196K
Net other financing activities
---20K
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
3.87%-5.24M
-77.96%2.48M
-3,535.90%-1.34M
118.51%2.83M
37.78%-3.03M
-135.50%-5.45M
301.72%11.26M
101.56%39K
-186.90%-15.27M
-783.85%-4.87M
Net cash flow
Beginning cash position
-13.86%8.81M
-68.96%7.31M
-24.09%12.84M
-40.46%16.91M
-53.08%10.08M
-53.36%10.22M
-19.50%23.54M
-40.46%16.91M
-8.31%28.41M
-20.06%21.48M
Current changes in cash
1,839.73%2.54M
111.25%1.5M
-183.41%-5.53M
64.55%-4.08M
160.50%2.76M
67.12%-146K
-81.82%-13.32M
689.29%6.63M
-346.72%-11.49M
-396.17%-4.56M
End cash Position
12.59%11.35M
-13.86%8.81M
-68.96%7.31M
-24.09%12.84M
-24.09%12.84M
-53.08%10.08M
-53.36%10.22M
-19.50%23.54M
-40.46%16.91M
-40.46%16.91M
Free cash flow
-72.80%1.74M
-19.22%1.25M
-183.08%-4.83M
294.21%19.12M
153.41%5.35M
291.87%6.41M
174.28%1.55M
82.69%5.82M
76.30%4.85M
6.02%2.11M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -7.71%12.75M33.57%10.18M-88.81%1.18M62.94%45.21M72.88%13.28M73.22%13.81M54.12%7.62M46.88%10.5M23.36%27.75M-11.22%7.68M
Net income from continuing operations 33.78%3.91M-36.61%1.48M5.67%1.6M64.63%10.24M42.62%3.48M176.68%2.92M140.95%2.33M-13.90%1.52M-31.82%6.22M-40.35%2.44M
Operating gains losses -60.42%-616K-259.14%-592K356.14%146K127.16%160K138.54%229K-284.62%-384K166.91%372K83.09%-57K25.73%-589K130.48%96K
Depreciation and amortization 7.25%6.41M21.19%6.31M31.98%6.29M39.87%21.86M35.35%5.92M44.99%5.98M39.24%5.21M40.18%4.76M38.17%15.63M40.16%4.37M
Deferred tax -5,213.64%-3.51M--0--0-182.42%-1.44M-164.74%-648K---66K--0-197.32%-725K-55.05%1.75M-32.09%1M
Other non cash items 424.07%175K2,664.15%1.36M3.51%-55K---219K---55K---54K---53K---57K--------
Change In working capital 44.30%4.52M103.85%58K-338.83%-8.29M6,370.97%7.78M258.73%2.68M226.35%3.13M-158.43%-1.51M275.73%3.47M99.09%-124K45.27%-1.69M
-Change in receivables 136.36%12K-598.64%-2.2M-540.38%-6.03M58.61%-1.06M-32.24%-525K95.25%-33K-84.00%441K77.71%-941K65.20%-2.56M77.60%-397K
-Change in inventory 158.25%113K142.73%191K119.69%279K-256.81%-472K110.61%42K40.31%-194K-27.71%-447K-90.74%127K241.98%301K-2,375.00%-396K
-Change in prepaid assets -33.98%-1.18M-12.48%1.42M-77.95%99K176.67%2.18M2,971.88%983K60.51%-883K387.46%1.63M760.29%449K-1,155.75%-2.84M-98.43%32K
-Change in payables and accrued expense 8.62%2.96M335.46%3.25M-222.40%-3.04M83.77%4.1M127.67%269K-22.84%2.73M-1,849.37%-1.38M708.07%2.49M157.37%2.23M65.48%-972K
-Change in other working capital 72.58%2.62M-49.60%-2.61M-69.78%407K10.66%3.03M4,245.45%1.91M122.11%1.52M-364.95%-1.75M-0.37%1.35M244.94%2.74M108.54%44K
Cash from discontinued investing activities
Operating cash flow -7.71%12.75M33.57%10.18M-88.81%1.18M62.94%45.21M72.88%13.28M73.22%13.81M54.12%7.62M46.88%10.5M23.36%27.75M-11.22%7.68M
Investing cash flow
Cash flow from continuing investing activities 41.60%-4.97M65.33%-11.17M-37.39%-5.37M-117.35%-52.11M-1.56%-7.49M-39.41%-8.51M-381.56%-32.21M-2.57%-3.91M-21.42%-23.98M-12.42%-7.38M
Net PPE purchase and sale 29.51%-4.97M-60.82%-8.17M-37.39%-5.37M-7.65%-23.51M-38.94%-7.47M-15.88%-7.05M23.82%-5.08M-5.34%-3.91M-14.04%-21.84M18.06%-5.38M
Net business purchase and sale --0-----------28.59M-100.71%-1K-7,195.00%-1.46M----------0--141K
Net investment purchase and sale ------------99.07%-20K-------------------2.14M----
Cash from discontinued investing activities
Investing cash flow 41.60%-4.97M65.33%-11.17M-37.39%-5.37M-117.35%-52.11M-1.56%-7.49M-39.41%-8.51M-381.56%-32.21M-2.57%-3.91M-21.42%-23.98M-12.42%-7.38M
Financing cash flow
Cash flow from continuing financing activities 3.87%-5.24M-77.96%2.48M-3,535.90%-1.34M118.51%2.83M37.78%-3.03M-135.50%-5.45M301.72%11.26M101.56%39K-186.90%-15.27M-783.85%-4.87M
Net issuance payments of debt 3.16%-5.21M-75.25%2.62M---683K136.26%2.12M28.83%-3.1M-937.38%-5.38M2,355.53%10.6M--0-45.99%-5.84M-690.56%-4.36M
Net common stock issuance -34.78%-93K47.62%-11K-90.30%-961K93.88%-594K100.14%1K96.33%-69K99.59%-21K74.83%-505K-577.20%-9.71M---710K
Proceeds from stock option exercised by employees 1,416.67%91K-96.93%21K-44.12%304K360.42%1.3M-64.80%69K-93.10%6K--684K--544K152.68%283K--196K
Net other financing activities ---20K------------------------------------
Cash from discontinued financing activities
Financing cash flow 3.87%-5.24M-77.96%2.48M-3,535.90%-1.34M118.51%2.83M37.78%-3.03M-135.50%-5.45M301.72%11.26M101.56%39K-186.90%-15.27M-783.85%-4.87M
Net cash flow
Beginning cash position -13.86%8.81M-68.96%7.31M-24.09%12.84M-40.46%16.91M-53.08%10.08M-53.36%10.22M-19.50%23.54M-40.46%16.91M-8.31%28.41M-20.06%21.48M
Current changes in cash 1,839.73%2.54M111.25%1.5M-183.41%-5.53M64.55%-4.08M160.50%2.76M67.12%-146K-81.82%-13.32M689.29%6.63M-346.72%-11.49M-396.17%-4.56M
End cash Position 12.59%11.35M-13.86%8.81M-68.96%7.31M-24.09%12.84M-24.09%12.84M-53.08%10.08M-53.36%10.22M-19.50%23.54M-40.46%16.91M-40.46%16.91M
Free cash flow -72.80%1.74M-19.22%1.25M-183.08%-4.83M294.21%19.12M153.41%5.35M291.87%6.41M174.28%1.55M82.69%5.82M76.30%4.85M6.02%2.11M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.